Navigation Links
New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients
Date:9/4/2008

ovascular reasons; 1,981 patients (57%) in the omega-3 acid ethyl esters group died or were admitted to the hospital for cardiovascular reasons compared to 2,053 patients (59%) in the placebo group. The rate of treatment discontinuation due to adverse reactions was the same in both groups. The most commonly reported adverse event was gastrointestinal disturbance and the rate of occurrence (3%) was similar in both groups.

About LOVAZA

LOVAZA is made from nature, and is the first and only U.S. Food and Drug Administration (FDA) approved omega-3 medicine. Along with a healthy diet, LOVAZA is approved to reduce very high triglycerides (greater than or equal to 500 mg/dL) in adults. LOVAZA has been shown to help reduce triglyceride levels by 45%. Treatment with LOVAZA also resulted in an increase in LDL-C by a median of 45%, from a median baseline of 89 mg/dL to 109 mg/dL at end of therapy.

Omega-3 fatty acids are a type of polyunsaturated fatty acids, also known as essential fatty acids, which are vital to human health. LOVAZA is derived from all-natural fish oils. Like cholesterol, triglycerides are fats (lipids) that, in balanced and moderate amounts, perform significant and important functions in the human body. However, when triglycerides levels are too high, they may cause some health problems.

Important safety information for LOVAZA (omega-3-acid ethyl esters)

LOVAZA, along with diet, helps to lower very high triglyceride levels.

If you are allergic to fish, you should not take LOVAZA.

Talk to your doctor about any medications you are taking, especially those that may increase your risk of bleeding.

Possible side effects include burping, infection, flu-like symptoms, and upset stomach.

For more information about LOVAZA, please see the Patient Information or full Prescribing Information.

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is com
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis
2. Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis
3. Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
4. TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent
5. National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births
6. Survey Shows Parents Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu
7. Study Shows Benefits of a High Omega-3 Diet in Older Adults
8. New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease
9. Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
10. Study Shows Use of AdvanDxs PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections
11. Device Blocking Stomach Nerve Signals Shows Promise in Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... FRANCISCO , July 1, 2015  goBalto, ... startup solutions, announced today unprecedented growth in serving ... is intense pressure to speed clinical trials and ... globalization, and paper-based methods have stalled these efforts," ... current status of clinical trials has encouraged Industry ...
(Date:7/1/2015)... Prismic Pharmaceuticals, Inc., a specialty pharmaceutical company ... announced the election of Joseph J. Krivulka ... of Directors. Commenting on the election of ... Chairman and CEO of Prismic, stated, "We are delighted ... have accepted our invitation to join Prismic,s Board ...
(Date:7/1/2015)... DIEGO , July 1, 2015  Imprimis ... company focused on the development and commercialization of ... company will ring The Nasdaq stock market closing ... celebrating the growing success of its Go Dropless™ ... 3.6 million cataract procedures are performed annually in ...
Breaking Medicine Technology:goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... 14 Medizone International, Inc. (OTC Bulletin ... AsepticSure(TM) trials have begun at Innovation Park, Queen,s University. ... and second round of laboratory testing, this third round ... in order to obtain maximum bactericidal action in combination ...
... , TROY, Mich., Oct. 14 Somanetics Corporation (Nasdaq: ... an Exclusive Sublicense Agreement with Raba Equity Partners II, ... Somanetics has obtained exclusive rights, subject to specified rights ... Johns Hopkins University, to new cerebral autoregulation technology developed ...
Cached Medicine Technology:Medizone International Announces Third Round of AsepticSure 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 4Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5
(Date:7/2/2015)... ... ... Every year, DUI arrests and fatalities spike on the 4th of July. In fact, because ... when it comes to being on the road. According to attorney David J. Maloney ... of all highway deaths between 2007 and 2011 were caused by drunk driving over the ...
(Date:7/2/2015)... ... ... what we consume can have an effect on the body. And during the hot summer season, ... undernourished if not eating enough of the right foods, as well as drinking plenty of water. ... overdo it on the food front as well, with sweet treats like ice cream and snow ...
(Date:7/2/2015)... ... July 02, 2015 , ... Cs ... for Semiconductor Timing announced the release and publication of their newest offering to ... based publication and Newsletter. , Designed in support of coverage for the ...
(Date:7/1/2015)... ... ... In the United States, summer has always been the season to travel ... Dubai, the summer temperatures are so hot, that July vacationers often leave their home ... ORA Dentistry Spa notes that a trip to the United States, and Los Angeles ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... against the manufacturers of Levaquin ( http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the Defendants’ Motion ... Southern District of West Virginia on June 26th, the Court rejected the Plaintiff’s ...
Breaking Medicine News(10 mins):Health News:Attorney David Maloney Stresses Safety through Sobriety 2Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3
... $15.0 Billion Decreased 7.2% Versus 2008 First Quarter; , EPS ... 14 Johnson & Johnson (NYSE: JNJ ) ... of 2009, a decrease of 7.2% as compared to the ... negative impact of currency was 6.0%. Domestic sales declined 5.0%, ...
... Website Link to Introduce Consumers to Progesterone ... the leading voice for women and men ... (RESOLVE) announces their partnership with Woburn, MA-based ... Inc., makers of progesterone suppository compounding kits ...
... second approved antibody generated from Medarex,s UltiMAb(R) technology ... (Nasdaq: MEDX ) today announced that ... undisclosed amount from its licensing partner, Centocor Ortho ... from Health Canada,s Biologics and Genetic Therapies Directorate, ...
... IN AFFORDABILITYINDIANAPOLIS, April 14 AMD LASERS(TM), the company ... today announces the launch of the Picasso soft tissue ... sleek and compact design, ease of use, comprehensive clinical ... itself apart as a high-quality laser with distinctive features ...
... is a great way to stay fit. Whether your ... marathon, or maintain that figure you worked so hard to ... spring training.(Photo: http://www.newscom.com/cgi-bin/prnh/20090414/NYFNSX02 ) The first step ... the right pair of shoes. Lady Foot Locker ( ...
... With summer quickly approaching, the consequences of those long ... you,ll never visit, or swearing you,ll eventually start eating better ... begin crunching those abs or counting calories, start by exercising ... those of your family. Health and fitness articles at ...
Cached Medicine News:Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 2Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 3Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 4Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 5Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 6Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 7Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 8Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 9Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 10Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 11Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 12Health News:Johnson & Johnson Reports 2009 First-Quarter Results: 13Health News:RESOLVE: The National Infertility Association Announces Partnership With CutisPharma 2Health News:Medarex to Receive Milestone Payment for Approval of SIMPONI(TM) for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2Health News:Medarex to Receive Milestone Payment for Approval of SIMPONI(TM) for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3Health News:AMD LASERS(TM) Introduces the Picasso Diode Laser 2Health News:Expert Running Advice for Getting Fit this Spring 2Health News:How To Get Fit By Summer; Life123 Helps Feed Your Mind and Improve Your Health 2
PT, PTT, Fibrinogetn & TT Normal and Abnormal Controls...
ApolipoproteinA-1 & B Calibrator...
CRP Calibrator...
Drug controls sera available in three levels for the control of accuracy and percision for up to 18 analytes...
Medicine Products: